Nanoemulsion: for improved oral delivery of repaglinide

Drug Delivery

Volumn 23, Issue 6, 2016, Pages 2026-2034

  Akhtar, Juber ^a   Siddiqui, Hefazat Hussain ^a   Fareed, Sheeba ^b   Badruddeen, ^a   Khalid, Mohammad ^a   Aqil, Mohammed ^c  

^a INTEGRAL UNIVERSITY   (India)

^b Women Center for Higher Education   (Saudi Arabia)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Diabetes mellitus; nanoemulsion; pseudoternary phase diagrams; repaglinide; streptozotocin

Indexed keywords

GLUCOSE; REPAGLINIDE; ANTIDIABETIC AGENT; CARBAMIC ACID DERIVATIVE; EMULSION; LIPID; NANOPARTICLE; PIPERIDINE DERIVATIVE; POLYSORBATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ELECTRIC CONDUCTIVITY; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHASE SEPARATION; PRIORITY JOURNAL; RAT; REFRACTION INDEX; SINGLE DRUG DOSE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SURFACE AREA; TABLET FORMULATION; THERMODYNAMICS; THERMOSTABILITY; TITRIMETRY; TREATMENT RESPONSE; VISCOSITY; ANIMAL; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG STABILITY; EMULSION; METABOLISM; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PHARMACOKINETICS; SOLUBILITY;

ADMINISTRATION, ORAL; ANIMALS; BIOPHARMACEUTICS; CARBAMATES; DIABETES MELLITUS, EXPERIMENTAL; DRUG STABILITY; EMULSIONS; HYPOGLYCEMIC AGENTS; LIPIDS; NANOPARTICLES; PIPERIDINES; POLYSORBATES; RATS; SOLUBILITY;

EID: 84940469691     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1077290     Document Type: Article

References (23)

1. J.Akhtar, S.Fareed, M.Aqil. (2013). Stability-indicating assay of repaglinide in bulk and optimized nanoemulsion by validated high performance thin layer chromatography technique. J Pharm Bioallied Sci 5:184–90
2. J.Akhtar, H.Hussain Siddiqui, Badruddeen,. (2014). Nanomulsion as a carrier for efficient delivery of metformin. Curr Drug Deliv 11:243–52
3. D.K.Arulmozhi, A.Veeranjaneyulu, S.L.Bodhankar. (2004). Neonatal streptozotocin-induced rat model of Type 2 diabetes mellitus: a glance. Indian J Pharmacol 36:217–18
4. S.Arunachalam, S.Gunasekaran,. (2002). Tuberculosis research in India and China: from bibliometrics to research policy. Curr Sci 82:933–47
5. A.Azeem, M.Rizwan, F.J.Ahmad,. (2009). Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 10:69–76
6. N.Chennamsetty, H.Bock, L.F.Scanu,. (2005). Cosurfactant and cosolvent effects on surfactant self-assembly in supercritical carbon dioxide. J Chem Phys 122:094710–11
7. M.Faiyazuddin, S.Baboota, J.Ali,. (2010). Chromatographic analysis of trans and cis-citral in lemongrass oil and in a topical phytonanocosmeceutical formulation, and validation of the method. J Planar Chromatogr Mod TLC 23:233–6
8. J.Fuhlendorff, P.Rorsman, H.Kofod,. (1998). Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 47:345–51
9. P.K.Ghosh, R.S.R.Murthy. (2006). Microemulsions: a potential drug delivery system. Curr Drug Deliv 3:167–80
10. A.Gumieniczek, M.Krzywdzinska, M.Nowak,. (2009). Modulation of nitrosative/oxidative stress in the lung of hyperglycemic rabbits by two antidiabetics, pioglitazone and repaglinide. Exp Lung Res 35:371–9
11. N.R.Hadi, F.A.Rezeg, F.Al-Amran,. (2012). Evaluation of the effects of glimepiride (Amaryl) and repaglinide (novoNorm) on atherosclerosis progression in high cholesterol-fed male rabbits. J Cardiovasc Dis Res 3:5–11
12. K.Ikebukuro, Y.Adachi, Y.Yamada,. (2002). Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats. Transplantation 73:512–18
13. M.J.Lawrence, G.D.Rees. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–21
14. T.W.Leonard, J.Lynch, M.J.McKenna,. (2006). Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET™. Expert Opin Drug Deliv 3:685–92
15. W.Mehnert, K.Mäder. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–96
16. G.Mustafa, Z.I.Khan, T.Bansal, S.Talegaonkar. (2009). Preparation and characterization of oil in water nano-reservoir systems for improved oral delivery of atorvastatin. Curr Nanosci 5:428–40
17. R.Parveen, S.Baboota, J.Ali,. (2011). Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies. Int J Pharm 413:245–53
18. L.Ping, A.Ghosh, R.F.Wagner,. (2005). Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm 288:27–34
19. P.S.Prasad, S.S.Imam, M.Aqil,. (2014). QbD-based carbopol transgel formulation. Characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes. Drug Deliv. [Epub ahead of print]. http://dx.doi.org/10.3109/10717544.2014.936536
20. M.A.Rahman, A.Hussain, M.S.Hussain,. (2013). Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm 39:1–19
21. F.Ries, J.Klastersky. (1986). Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8:368–79
22. F.Shakeel, M.S.Faisal. (2010). Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib. Pharm Dev Technol 15:53–6
23. K.D.Tripathi. (2003). Essential of medical pharmacology. New Delhi: Jaypee Brother’s Medical Publishers (P) Ltd., 247–51